Revenue Comparison
Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Pfizer 15.034, AstraZeneca 15.384.
Pfizer vs AstraZeneca Net Worth and Market Cap
Pfizer (PFE) and AstraZeneca (AZN) are peers in GLP-1. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $15.4B for AstraZeneca. AstraZeneca leads on revenue.
Pfizer's gross margin is 72.8% versus 83.6% for AstraZeneca. Pfizer's net margin is -1.6% versus 16.3% for AstraZeneca.
Key differences
- Revenue growth from Q2 2025 to Q2 2026: AstraZeneca +6.4%, Pfizer +2.6%.
- Pfizer keeps more of its revenue as operating profit: a 31.3% operating margin, against 20.6% at AstraZeneca.
- Pfizer's KPIs on Sterling include Abrysvo Revenues by Region (Quarterly) and Comirnaty Revenues by Region (Quarterly).
- AstraZeneca's KPIs on Sterling include Alliance Revenue by Partnered Medicine (Quarterly) and AZD5004 + AZD6234 Trial Timeline: Oral GLP-1 + Oral Amylin.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, AstraZeneca.| Metric | Pfizer | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $15.38B |
| Cost of Revenue | $4.09B | $2.52B |
| Gross Profit | $10.94B | $12.86B |
| Operating Income | $4.71B | $3.16B |
| Net Income | $-246.00M | $2.51B |
| R&D Expense | $2.81B | $4.05B |
| Earnings Per Share | -$0.04 | $1.59 |
| Gross Margin | 72.8% | 83.6% |
| Operating Margin | 31.3% | 20.6% |
| Net Profit Margin | -1.6% | 16.3% |
| Free Cash Flow | $302.00M | $2.13B |
| Cumulative Free Cash Flow | $356.70B | $121.22B |
| Operating Cash Flow | $835.00M | $2.89B |
| Cash & Equivalents | $976.00M | $4.89B |